Sign up UNITED KINGDOM
Proactive Investors - Run By Investors For Investors

ReNeuron heads west to find new home in Wales

Stem cell specialist ReNeuron Group will start life in new facilities in Wales next month.
ReNeuron heads west to find new home in Wales
The firm is a stem cell specialist...

Stem cell specialist ReNeuron Group (LON:RENE) will start life in new facilities in Wales next month.

From February 29, the firm said its headquarters, research laboratories and manufacturing facilities will be housed in a new purpose-built building on the Pencoed Business Park, just off the M4 in South Wales. Previously the firm was based in Guildford.

Olav Hellebø, chief executive, said: "We are delighted to be moving ReNeuron's existing operations to our new facility at Pencoed, South Wales.

"When fully complete and licensed, we believe the building will house one of the world's most advanced commercial cell therapy manufacturing facilities and we look forward to continuing to work with the Welsh Government to bring this important project to fruition."

View full RENE profile View Profile

ReNeuron Group Plc Timeline

Related Articles

generic pill and bottle shot to denote Alliance's products
August 14 2017
The company has made the transition from a business capitalised at £90mln to company now worth around a quarter of a billion pounds - but has the market at large picked up on (and priced in) the transformation?
newspaper with word cancer magnified
July 11 2017
"In our view, the potential for SCIB1 [Scancell's skin cancer treatment], as already demonstrated by the survival data, is remarkable," said one broker recently
hepatitisC.jpg
July 27 2017
Regulatory sign-off will fire the starting pistol on the commercial launch in Europe

© Proactive Investors 2017

Proactive Investor UK Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use